Streaming difference(s): Netflix and the branding of diversity
Critical Studies in Television: The International Journal of Television Studies · 2023-03 · 18 (1) · 24-40
DOI: 10.1177/17496020221129516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Critical Studies in Television: The International Journal of Television Studies, online erschienen am 21.09.2022. Verfasst von Axelle Asmar und 2 weiteren Autor:innen. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Since 2020, Netflix has emphasised the diversity of representation the platform provides through its content. Following the publication of its diversity report, the streamer positions itself as a driver of inclusion for underrepresented communities in film and television industries. This article examines how Netflix rhetorically frames the emphasis on diversity in its corporate communication. Based on a thematic analysis of Netflix’s press releases, it explores how Netflix uses its branding of diversity to generate a transnational appeal. The article outlines four strategies which highlight the cultural and industrial practices deployed by the streamer to gain competitive advantages.
Zitieren
APA
Asmar, A., Raats, T., & Audenhove, L. V. (2023). Streaming difference(s): Netflix and the branding of diversity. Critical Studies in Television: The International Journal of Television Studies, 18(1), 24-40. https://doi.org/10.1177/17496020221129516
Vancouver
Asmar A, Raats T, Audenhove LV. Streaming difference(s): Netflix and the branding of diversity. Critical Studies in Television: The International Journal of Television Studies. 2023;18(1):24-40. doi:10.1177/17496020221129516
BibTeX
@article{Asmar2023,
author = {Asmar, Axelle and Raats, Tim and Audenhove, Leo Van},
title = {Streaming difference(s): Netflix and the branding of diversity},
journal = {Critical Studies in Television: The International Journal of Television Studies},
year = {2023},
volume = {18},
number = {1},
pages = {24--40},
doi = {10.1177/17496020221129516}
}
EUVIMED